Showing results (1-10 of 303) with videos related to
Sort By:
Pageof 31
Trends in Endocrinology and Metabolism: TEM|December 3, 2014
Cholesterol and breast cancer pathophysiologyErik R Nelson, Ching-yi Chang, Donald P McDonnellMolecular Endocrinology (Baltimore, Md.)|March 30, 2002
Evaluation of ligand-dependent changes in AR structure using peptide probesChing-Yi Chang, Donald P McDonnellTrends in Pharmacological Sciences|April 30, 2005
Androgen receptor-cofactor interactions as targets for new drug discoveryChing-yi Chang, Donald P McDonnellClinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2012
Molecular pathways: the metabolic regulator estrogen-related receptor α as a therapeutic target in cancerChing-yi Chang, Donald P McDonnellEndocrine Reviews|May 9, 2025
The Roles of Natural Killer Cells in Breast Cancer Pathobiology and their Regulation by EstrogensJovita Byemerwa, Ching-Yi Chang, Donald P McDonnellTrends in Endocrinology and Metabolism: TEM|November 28, 2022
Eosinophilia in cancer and its regulation by sex hormonesSandeep Artham, Ching-Yi Chang, Donald P McDonnellCancer Cell|February 14, 2018
Neomorphic ERα Mutations Drive Progression in Breast Cancer and Present a Challenge for New Drug DiscoveryDonald P McDonnell, John D Norris, Ching-Yi ChangBone|November 22, 2012
The molecular mechanisms underlying the pharmacological actions of estrogens, SERMs and oxysterols: implications for the treatment and prevention of osteoporosisErik R Nelson, Suzanne E Wardell, Donald P McDonnellMolecular Endocrinology (Baltimore, Md.)|July 30, 2005
Development of peptide antagonists for the androgen receptor using combinatorial peptide phage displayChing-Yi Chang, Jennifer Abdo, Tanya Hartney, et al.Steroids|August 2, 2014
From empirical to mechanism-based discovery of clinically useful Selective Estrogen Receptor Modulators (SERMs)Suzanne E Wardell, Erik R Nelson, Donald P McDonnellPageof 31